ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
Diagnosis & Disease Information
FDA Panel Votes on Polivy Combo for First-Line Treatment of DLBCL
An FDA panel voted in favor of approving polatuzumab vedotin in combination with R-CHP for previously untreated DLBCL.
Chest CT Prior to Allo-HSCT Deemed Beneficial for Spotting Abnormalities
Patients with abnormal chest CTs had worse overall survival, nonrelapse mortality, and pulmonary-related death after allo-HSCT.
Clonal Hematopoiesis More Prevalent in Pediatric Cancer Survivors
Survivors of pediatric cancer have a higher rate of clonal hematopoiesis than their peers at any age, a study suggests.
Zamtocabtagene Autoleucel Produces High ORR in Relapsed/Refractory DLBCL
Zamtocabtagene autoleucel produced responses in patients with relapsed/refractory diffuse large B-cell lymphoma in a phase 2 trial.
“Severe4” Predicts Outcomes of CAR T-Cell Therapy in Relapsed/Refractory DLBCL
A prognostic index called “Severe4” can predict outcomes of CAR T-cell therapy in patients with relapsed/refractory DLBCL, a study suggests.
At-Home Medication Errors May Be Common for Children With Leukemia, Lymphoma
Medication errors may be common in children with leukemia or lymphoma, and these errors can lead to serious harm, a new study suggests.
Treatment May Increase Risk of Colorectal Cancer in Hodgkin Lymphoma Survivors
Hodgkin lymphoma patients treated with subdiaphragmatic radiation and/or procarbazine have an increased risk of developing colorectal cancer, a study suggests.
Jaypirca Approved for Relapsed/Refractory Mantle Cell Lymphoma
As a noncovalent inhibitor of BTK, pirtobrutinib is able to reestablish BTK inhibition in patients previously treated with covalent BTK inhibitors.
Epcoritamab Shows Promise in Large B-Cell Lymphoma
Epcoritamab elicits durable responses in patients with relapsed or refractory large B-cell lymphoma.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...